Endovascular therapy is becoming an attractive initial strategy adopted ... The atheroablative laser technology that is currently available is the CVX-300 excimer laser (Spectranetics Corporation).

Excimer laser angioplasty has been studied since the late 1980s for peripheral vascular disease. However, widespread adoption has been limited by misunderstanding data from various laser studies in ...

Potential advantages of excimer laser treatment are more rapid improvement, longer remission times compared to topical creams, and avoidance of unnecessary exposure to healthy, unaffected skin.

Bausch + Lomb's acquisition of Elios Vision introduces the ELIOS procedure, a minimally invasive glaucoma surgery using an excimer laser. The ELIOS system offers a non-thermal, tissue-friendly ...